A novel treatment for Leber's Hereditary Optic Neuropathy (LHON), a rare genetic disease that can lead to sudden loss of ...

A novel treatment for Leber's Hereditary Optic Neuropathy (LHON), a rare genetic disease that can lead to sudden loss of vision, has been approved for ...

Please provide your email address to receive an email when new articles are posted on . A 65-year-old woman presented to the New England Eye Center with 4 weeks of decreased vision and 6 months of ...

New research links two widely used diabetes drugs, semaglutide or tirzepatide, to a rare but potentially vision-threatening eye condition, raising questions about drug-specific risks and the need for ...

Semaglutide exposure was significantly associated with a higher incidence rate and independently predicted a higher risk for upcoming nonarteritic anterior ischemic optic neuropathy. HealthDay News — ...

Researchers found that among semaglutide users, the incidence rate of nonarteritic anterior ischemic optic neuropathy was 14.5 per 100,000 person-years. HealthDay News — For individuals with type 2 ...

"Leber's Hereditary Optic Neuropathy (LHON) Market Insight, Epidemiology And Market Forecast - 2032" The Leber Hereditary Optic Neuropathy market in the 7MM is set for strong growth, driven by ...